News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roche (RHHBY)'s Genentech (RHHBY)'s Drug Positive in Mid-Stage Skin Cancer Trial


6/20/2011 8:02:11 AM

Swiss pharmaceutical giant Roche Holding AG's (RHHBY.PK: News ) unit Genentech Monday stated that its investigational drug vismodegib showed positive results in a pivotal phase II study in people with basal cell carcinoma, an advanced form of skin cancer.

Read at Reuters
Read at RTT News
Read at InPharm.com

comments powered by Disqus
Roche
Roche
Genentech
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES